CYTOSORBENTS CORP (CTSO) Covered Calls

Cytosorbents Corp is a immunotherapy company. The Company uses blood purification to modulate inflammation with the goal of preventing or treating multiple organ failure in life-threatening illnesses.

You can sell covered calls on CYTOSORBENTS CORP to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CTSO (prices last updated Tue 4:16 PM ET):

CYTOSORBENTS CORP (CTSO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
10.88 +0.13 10.71 11.23 164K - 0.3B
Covered Calls For CYTOSORBENTS CORP (CTSO)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Oct 19 10 0.65 10.58 -5.5% -501.9%
Nov 16 10 1.15 10.08 -0.8% -9.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

CytoSorbents Corp. is a development stage critical care focused company using blood purification to treat life-threatening illnesses. The technology is based upon biocompatible, porous polymer sorbent beads that are capable of extracting unwanted substances, such as drugs, dangerous chemicals, toxins, cytokines, free hemoglobin, and antibodies, from blood and other bodily fluids. The company was founded on April 25, 2002 and is headquartered in Monmouth Junction, NJ.